2022
DOI: 10.7326/aitc202203150
|View full text |Cite
|
Sign up to set email alerts
|

Type 1 Diabetes Mellitus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
54
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 106 publications
(69 citation statements)
references
References 24 publications
0
54
1
Order By: Relevance
“…Unfortunately, the mean HbA1c across all age groups reported in the cost, coverage and care (3C) study in China remains as high as 8.9%, and most T1DM individuals fail to achieve desired glycemic control (HbA1c less than 7.5%) ( 4 , 5 ). The optimal management of T1DM patients requires adherence to both lifestyle management and therapeutic regimens ( 6 ). The self-management of diabetes is necessary to achieve treatment goals for individuals with T1DM ( 7 ).…”
Section: Introductionmentioning
confidence: 99%
“…Unfortunately, the mean HbA1c across all age groups reported in the cost, coverage and care (3C) study in China remains as high as 8.9%, and most T1DM individuals fail to achieve desired glycemic control (HbA1c less than 7.5%) ( 4 , 5 ). The optimal management of T1DM patients requires adherence to both lifestyle management and therapeutic regimens ( 6 ). The self-management of diabetes is necessary to achieve treatment goals for individuals with T1DM ( 7 ).…”
Section: Introductionmentioning
confidence: 99%
“…During the development of type 1 diabetes, there is often a significant weight loss due to decreased insulin secretion before the diagnosis. Rapid weight gain often occurs after insulin administration [ 33 , 34 , 35 ]. Some patients start to reduce their insulin dose in order to reduce their weight gain, causing subsequent weight loss.…”
Section: Anorexia Nervosamentioning
confidence: 99%
“…Type 1 diabetes mellitus (T1DM), with insulin-secreting pancreatic β-cells incorrectly destroyed by the immune system, has affected millions of people worldwide. [1,2] Up to the present time, injection with exogenous insulin every day is still the most commonly used strategy to control blood glucose for T1DM treatment. [3] However, the administration of exogenous insulin cannot satisfy the regulation of blood glucose realized by β-cells and is still associated with a high risk of diabetes complications.…”
Section: Introductionmentioning
confidence: 99%